Canaccord Genuity Maintains a 'Sell' on Seattle Genetics (SGEN); Current Valuation Overrepresents Ultimate Market Opportunity
Tweet Send to a Friend
Canaccord Genuity maintains a 'Sell' on Seattle Genetics (NASDAQ: SGEN), PT $10.
Canaccord analyst, Dr. George Farmer, said, "We recommend ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst, Dr. George Farmer, said, "We recommend ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
